HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
prostate biopsy

A prostate biopsy is a diagnostic procedure performed to investigate abnormalities or suspected conditions within the prostate gland. The prostate, a small, walnut-sized organ located below the bladder in men, plays a crucial role in the reproductive system by producing seminal fluid. During a prostate biopsy, a healthcare professional obtains small tissue samples from the prostate for further examination. The procedure is typically recommended when other diagnostic tests, such as a prostate-specific antigen (PSA) blood test or a digital rectal examination (DRE), indicate the presence of abnormalities. The biopsy is commonly conducted using a thin, needle-like device that is inserted through the rectum or the perineum (the area between the scrotum and anus). Ultrasound imaging may be employed to guide the biopsy and ensure precise targeting of suspicious areas. Patients may receive local anesthesia to minimize discomfort during the procedure. The collected tissue samples are then sent to a pathology laboratory for analysis. Results from the biopsy help healthcare professionals determine whether the prostate tissue shows signs of cancer, inflammation, or other conditions. While a prostate biopsy is a valuable tool for diagnosing prostate-related issues, it is not without risks. Potential side effects may include temporary bleeding, infection, or discomfort. However, the benefits of obtaining accurate diagnostic information often outweigh the potential risks, enabling healthcare providers to make informed decisions about treatment options based on the biopsy results. It's important for individuals undergoing a prostate biopsy to discuss any concerns or questions with their healthcare provider beforehand, ensuring a thorough understanding of the procedure, its purpose, and potential outcomes. Regular communication between patients and healthcare professionals is key to managing the overall health and well-being of individuals undergoing prostate biopsies.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp